On the use of discrete choice models for causal inference
暂无分享,去创建一个
Sharon-Lise T Normand | S. Normand | R. Tchernis | M. Horvitz-Lennon | Marcela Horvitz-Lennon | Rusty Tchernis
[1] M. Heo,et al. Antipsychotic-induced weight gain: a comprehensive research synthesis. , 1999, The American journal of psychiatry.
[2] Stephan Arndt,et al. Clozapine use in patients with schizophrenia and the risk of diabetes, hyperlipidemia, and hypertension: a claims-based approach. , 2001, Archives of general psychiatry.
[3] P. Schmidt,et al. Limited-Dependent and Qualitative Variables in Econometrics. , 1984 .
[4] D. Rubin,et al. The central role of the propensity score in observational studies for causal effects , 1983 .
[5] G. Maddala. Limited-dependent and qualitative variables in econometrics: Introduction , 1983 .
[6] P. Rosenbaum,et al. Invited commentary: propensity scores. , 1999, American journal of epidemiology.
[7] M. Weeks. The Multinomial Probit Model Revisited: A Discussion of Parameter Estimability, Identification and Specification Testing , 1997 .
[8] P. Rosenbaum. The Consequences of Adjustment for a Concomitant Variable that Has Been Affected by the Treatment , 1984 .
[9] D. Horvitz,et al. A Generalization of Sampling Without Replacement from a Finite Universe , 1952 .
[10] Paul R. Rosenbaum,et al. Comparison of Multivariate Matching Methods: Structures, Distances, and Algorithms , 1993 .
[11] C. Korenyi,et al. Chlorpromazine induced diabetes. , 1968, Diseases of the nervous system.
[12] G. Imbens. The Role of the Propensity Score in Estimating Dose-Response Functions , 1999 .
[13] R. D'Agostino. Adjustment Methods: Propensity Score Methods for Bias Reduction in the Comparison of a Treatment to a Non‐Randomized Control Group , 2005 .
[14] B. Sheitman,et al. Olanzapine-induced elevation of plasma triglyceride levels. , 1999, The American journal of psychiatry.
[15] Elaine L. Zanutto,et al. Matching With Doses in an Observational Study of a Media Campaign Against Drug Abuse , 2001, Journal of the American Statistical Association.
[16] Paul R. Rosenbaum,et al. Balanced Risk Set Matching , 2001 .
[17] J. Geweke,et al. Alternative computational approaches to inference in the multinomial probit model , 1994 .
[18] M. Lechner. Identification and Estimation of Causal Effects of Multiple Treatments Under the Conditional Independence Assumption , 1999, SSRN Electronic Journal.
[19] D. Rubin. Randomization Analysis of Experimental Data: The Fisher Randomization Test Comment , 1980 .
[20] S. Marder,et al. Novel antipsychotics: comparison of weight gain liabilities. , 1999, The Journal of clinical psychiatry.
[21] G. L’italien,et al. An assessment of the independent effects of olanzapine and risperidone exposure on the risk of hyperlipidemia in schizophrenic patients. , 2002, Archives of general psychiatry.
[22] Robert Rosenheck,et al. Association of diabetes mellitus with use of atypical neuroleptics in the treatment of schizophrenia. , 2002, The American journal of psychiatry.
[23] D. Basu. Randomization Analysis of Experimental Data: The Fisher Randomization Test , 1980 .
[24] J. Lindenmayer,et al. Olanzapine-induced ketoacidosis with diabetes mellitus. , 1999, The American journal of psychiatry.